IP Library Granted Patent US 7,846,723
Granted Patent B2
US 7,846,723 · App. 12/211,046 · Granted Dec 7, 2010

Methods of identifying anti-cancer agents and uses thereof

Assignee: The Trustees of the University of Pennsylvania
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,846,723
App. No.
12/211,046
Granted
Dec 7, 2010
Kind
B2
Abstract

The present invention provides methods of identifying and/or detecting anti-cancer agents. The present invention provides methods of identifying and/or detecting compounds that can activate PARP and/or induce necrosis. The present invention also provides for methods of treating cancer in an individual. The present invention also provides kits for identifying and/or detecting anti-cancer agents.

Claims (15)

1. A kit for identifying a PARP activator comprising:

1) a container comprising a plurality of immortalized cells that are apoptosis resistant, wherein said cells are deficient in Bax gene expression and Bak gene expression; and

2) an instruction manual; and

3) at least one reagent to detect PARP activation.

2. The kit of claim 1 , wherein said reagent to detect PARP activation is a reagent used in measuring PAR polymers, NAD depletion, or ATP depletion.

3. The kit of claim 1 , wherein the kit further comprises a positive control, wherein the positive control induces PARP activation or induces necrosis of a plurality of immortalized cells upon contact with said plurality of immortalized cells.

4. A kit for identifying a PARP activator comprising:

1) a container comprising a plurality of immortalized cells that are apoptosis resistant, wherein said cells are deficient in Bax gene expression and Bak gene expression; and

2) an instruction manual; and

3) a positive control, wherein the positive control induces PARP activation or induces necrosis of a plurality of immortalized cells upon contact with said plurality of immortalized cells.

5. The kit of claim 4 , wherein the positive control is N-methyl-N′-nitro N-nitrosoguandidine (MNNG).

6. The kit of claim 4 further comprising at least one reagent to detect PARD activation.

7. The kit of claim 6 , wherein said reagent to detect PARP activation is a reagent used in measuring PAR polymers, NAD depletion, or ATP depletion.

8. The kit of claim 4 further comprising at least one reagent to detect necrosis.

9. The kit of claim 8 , wherein said reagent to detect necrosis is a reagent used in measuring organelle swelling, intracellular vacuole formation, plasma membrane disintegration, or nuclear degradation without condensation.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 18, 2021
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 055637/0119 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2008
From: THOMPSON, CRAIG B; ZONG, WEI-XING
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 021693/0279 →
Continuity (3)
Division 1101357400 · Dec 15, 2004
Provisional Application 6052964200 · Dec 15, 2003
Related Publication 20090093458A1 · Apr 9, 2009